Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Merck administers dose to first patient in Phase III study of Oral Cladribine in Generalised…
Cladribine capsules have the potential to be the first oral treatment for gMG patients
Zydus receives USFDA warning letter for Jarod facility
Earlier, on July 18, the facility received an OAI status
Ministry of Science and Technology releases new BioE3 policy
The policy is aimed at ‘Fostering High-Performance Biomanufacturing’ aligned with National initiatives of the government of India…
Express Pharma September 2024
India's Foremost Pharma & Biotech Magazine ~ Making Sustainability Sustainable
Akums appoints Amrut Medhekar as CDMO CEO
He brings over 27 years of experience in the pharma industry. His expertise spans corporate strategy, business leadership, key…
Future-proofing pharma manufacturing: How companies and associations are upskilling to meet new…
Sumit Kumar, Chief Strategy Officer, TeamLease Degree Apprenticeship, highlights the importance of embracing apprenticeships,…
CDSCO reports low failure rate in cough syrup testing amid enhanced supply chain monitoring
Over 8,000 batches tested since July 2023, with only 2-3% failure rate; CDSCO strengthens regulatory measures ahead of winter…
Zydus Lifesciences receives U.S. FDA approval for Scopolamine Transdermal System
Zydus gains final approval to market Scopolamine Transdermal System, marking its fifth ANDA approval in the transdermal portfolio…
US FDA approves Emergent’s smallpox vaccine for people at high risk of mpox
FDA approves Emergent's ACAM2000 smallpox vaccine for high-risk mpox patients, amid ongoing global health concerns and recent…
COPD diagnosed prevalent cases across 7MM to reach 38.02 million in 2033, forecasts GlobalData
COPD diagnosed prevalent cases in 7MM set to increase, with significant age and regional variations, according to GlobalData